Page 10 - Haematologica March 2020

haematologica Journal of the Ferrata Storti Foundation
e116 Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma
Esperanza M Algarín, et al. http://www.haematologica.org/content/105/3/e116
e121 Conditions associated with polyclonal hypergammaglobulinemia in the IgG4-related disease era: a retrospective study from a hematology tertiary care center
Eric J. Zhao et al. http://www.haematologica.org/content/105/3/e121
e124 High-throughput platelet spreading analysis: a tool for the diagnosis of platelet-based bleeding disorders Abdullah O. Khan et al.
http://www.haematologica.org/content/105/3/e124
e129 Blood transcriptome and clonal T-cell correlates of response and non-response to eltrombopag therapy in a cohort of patients with chronic immune thrombocytopenia
Haiyu Zhang et al. http://www.haematologica.org/content/105/3/e129
e133 Endocytosis by macrophages: interplay of macrophage scavenger receptor-1 and LDL receptor-related protein-1 Eelke P. Béguin et al.
http://www.haematologica.org/content/105/3/e133
Case Reports
Case Reports are available online only at www.haematologica.org/content/105/3.toc
e138 Venetoclax in combination with carfilzomib, doxorubicin and dexamethasone restores responsiveness in an otherwise treatment-refractory multiple myeloma patient
Sarolta Bojtine Kovacs et al.
http://www.haematologica.org/content/105/3/e138
e141 Successful venetoclax salvage in the setting of refractory, dialysis-dependent multiple myeloma with t(11;14) Dawn Swan et al.
http://www.haematologica.org/content/105/3/e141
Haematologica 2020; vol. 105 no. 3 - March 2020 http://www.haematologica.org/